Jane Street’s Neos Therapeutics, Inc NEOS Stock Holding History

Jane Street’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-165,503	Closed	-$213K	–	6046
2019 Q2	$213K	Buy	165,503 +127,202	+332%	+$234K	﹤0.01%	4627
2019 Q1	$100K	Buy	38,301 +693	+2%	+$1.63K	﹤0.01%	4772
2018 Q4	$62K	Buy	+37,608	New	+$106K	﹤0.01%	4702

Other funds holding NEOS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jane Street's NEOS Position: Q3 2019 in Review

Jane Street sold out of Neos Therapeutics, Inc (NEOS) in Q3 2019, closing a stake of 165,503 shares — an estimated $213K sold.

Jane Street first reported a position in NEOS in Q4 2018 and held it in 3 quarters. The position peaked at $213K in Q2 2019. 51 funds tracked by Wall St. Rank hold NEOS as of Q3 2019.

Jane Street reported no remaining Neos Therapeutics, Inc position as of Q3 2019 after selling out during the quarter.
Jane Street sold 165,503 Neos Therapeutics, Inc shares in Q3 2019, an estimated $213K.
Jane Street first reported a position in Neos Therapeutics, Inc in Q4 2018 and held it in 3 quarters.
Jane Street's Neos Therapeutics, Inc position peaked at $213K in Q2 2019.
51 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.